<DOC>
	<DOCNO>NCT02633696</DOCNO>
	<brief_summary>This clinical trial phase I healthy volunteer intend describe oral bioavailability silybin-phosphatidylcholine complex calculate area curve ( AUC0- ? AUC0-12 ) administration dose oral silybin ( AUCo ) intravenous silybin ( AUC iv ) .</brief_summary>
	<brief_title>Study Investigate Absolute Bioavailability Oral Sylibin</brief_title>
	<detailed_description />
	<mesh_term>Silybin</mesh_term>
	<mesh_term>Silymarin</mesh_term>
	<criteria>Healthy individual men give write consent participate study , receive information design , project objective , risk moment refuse cooperation . Understand purpose study available perform hospital visit admission . Age 18 45 year . Healthy subject , without organic psychological pathology Clinical history physical examination within normal limit . Lack clinically relevant abnormality blood test ( hematology , biochemistry , virology ) urine test Vital sign electrocardiographic record normal range . Males childbearing potential partner must agree use highly effective method contraception ( surgical sterilization , double barrier method ) moment signing inform consent 6 month end participation study . Subjects suffer organic psychological pathology . Prior inclusion volunteer consider security parameter mention protocol ( biochemical marker kidney damage / liver normal range set laboratory ) . Subjects received prescription drug treatment last 15 day medication within 48 hour receive study medication . Subjects BMI 18 30 . Known hypersensitivity drug Suspected drug abuse Consumers alcohol daily / acute alcohol poison last week . Subjects smoke . Have donate blood last three month . Participation investigational drug study previous 3 month Not able follow instruction collaborate course study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Clinical trial</keyword>
	<keyword>Phase I</keyword>
	<keyword>Healthy volunteer</keyword>
	<keyword>Clinical Pharmacology</keyword>
	<keyword>Bioavailability</keyword>
	<keyword>Silybin</keyword>
	<keyword>Liver Trasplantation</keyword>
</DOC>